These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease. Toda-Brito H; Lopes L; Soares-Almeida L; Filipe P Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632930 [TBL] [Abstract][Full Text] [Related]
23. Molecular diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients. Jarboui MA; Sellami A; Sellami H; Cheikhrouhou F; Makni F; Ben Arab N; Ben Jemaa M; Ayadi A Mycoses; 2010 Jul; 53(4):329-33. PubMed ID: 19496933 [TBL] [Abstract][Full Text] [Related]
24. Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis. Hugle B; Solomon M; Harvey E; James A; Wadhwa A; Amin R; Bell-Peter A; Benseler S Arthritis Care Res (Hoboken); 2010 Nov; 62(11):1661-4. PubMed ID: 20583109 [TBL] [Abstract][Full Text] [Related]
25. Pneumocystis jiroveci pneumonia: high-resolution CT findings in patients with and without HIV infection. Kanne JP; Yandow DR; Meyer CA AJR Am J Roentgenol; 2012 Jun; 198(6):W555-61. PubMed ID: 22623570 [TBL] [Abstract][Full Text] [Related]
26. Role of CD8 lymphocytes and neutrophilic alveolitis in Pneumocystis jiroveci pneumonia. Vahid B; Bibbo M; Marik PE Scand J Infect Dis; 2007; 39(6-7):612-4. PubMed ID: 17577827 [TBL] [Abstract][Full Text] [Related]
27. Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus after rituximab therapy. Tsai MJ; Chou CW; Lin FC; Chang SC Lupus; 2012 Jul; 21(8):914-8. PubMed ID: 22287506 [TBL] [Abstract][Full Text] [Related]
28. Pneumocystis jiroveci pneumonia in an infant with severe folate deficiency. Crighton G; Haeusler G; Pati N; Connell TG Pediatr Infect Dis J; 2011 Aug; 30(8):721-3. PubMed ID: 21346686 [TBL] [Abstract][Full Text] [Related]
29. Pneumocystis pneumonia in humans is caused by P jiroveci not P carinii. Miller R Thorax; 2004 Jan; 59(1):83; author reply 83-4. PubMed ID: 14694260 [No Abstract] [Full Text] [Related]
33. [Unusual presentation of bilateral bullous Pneumocystis jiroveci pneumonia complicated with pneumothorax]. Pizarro P R; Valdés H C; Vitali C J Rev Chilena Infectol; 2007 Feb; 24(1):68-71. PubMed ID: 17369975 [TBL] [Abstract][Full Text] [Related]
34. Aggressive immunosuppressant reduction and long-term rejection risk in renal transplant recipients with Pneumocystis jiroveci pneumonia. Yang CY; Shih CJ; Yang WC; Lin CC Exp Clin Transplant; 2012 Aug; 10(4):344-9. PubMed ID: 22765304 [TBL] [Abstract][Full Text] [Related]
35. An epidemic of Pneumocystis jiroveci pneumonia in a renal transplantation center: role of T-cell lymphopenia. Brunot V; Pernin V; Chartier C; Garrigue V; Vetromile F; Szwarc I; Delmas S; Portalès P; Basset D; Mourad G Transplant Proc; 2012 Nov; 44(9):2818-20. PubMed ID: 23146531 [TBL] [Abstract][Full Text] [Related]
36. Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia. Roblot F; Imbert S; Godet C; Kauffmann C; Ragot S; Le Moal G; Roblot P; Rodier MH; Robert R; Becq-Giraudon B; Guilhot F Scand J Infect Dis; 2004; 36(11-12):848-54. PubMed ID: 15764172 [TBL] [Abstract][Full Text] [Related]
37. [A case of Pneumocystis jiroveci pneumonia that presented with cavity and cystic changes in a malignant thymoma patient]. Kono M; Fujii M; Akamatsu T; Suda T; Chida K Nihon Kokyuki Gakkai Zasshi; 2008 Apr; 46(4):297-301. PubMed ID: 18516993 [TBL] [Abstract][Full Text] [Related]
38. Ibrutinib-associated Pneumocystis jirovecii pneumonia. Lee R; Nayernama A; Jones SC; Wroblewski T; Waldron PE Am J Hematol; 2017 Nov; 92(11):E646-E648. PubMed ID: 28815693 [No Abstract] [Full Text] [Related]